Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
Holding BBIO?
Track your performance easily
BridgeBio Pharma (BBIO) Ownership Overview
20.66% Insiders
15.79% Mutual Funds
46.04% Other Institutional Investors
13.24% ETFs
4.27% Public Companies and Individual Investors
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail, and individual investors. Approximately 75.07% of the company’s stock is owned by Institutional Investors, 20.66% is owned by Insiders, and 4.27% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 17, 2024 | Kkr Genetic Disorder L.p. >10% Owner | xxxxxxxxxxxxx | $149350000 |
| Feb 13, 2024 | Hannah Valantine Director | xxxxxxxxxxxxx | $44476 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $825438 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1258029 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $3104974 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $3477505 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 25,260,971 | Insider | 13.37% | 582,012,772 | |
| 25,120,991 | Institution | 13.29% | 578,787,633 | |
| 13,476,430 | Institution | 7.13% | 310,496,947 | |
| 12,152,418 | Institution | 6.43% | 279,991,711 | |
| 9,959,504 | Insider | 5.59% | 229,466,972 | |
| 6,989,844 | Institution | 3.70% | 161,046,006 | |
| 6,068,125 | Institution | 3.21% | 139,809,600 | |
| 2,796,554 | Institution | 1.48% | 64,432,604 | |
| 1,747,000 | Institution | 0.92% | 40,250,880 | |
| 1,571,173 | Institution | 0.83% | 36,199,826 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,152,418 | Institution | 6.43% | 279,991,711 | |
| 1,571,173 | Institution | 0.83% | 36,199,826 | |
| 1,553,457 | Institution | 0.82% | 35,791,649 | |
| 1,490,722 | Institution | 0.79% | 34,346,235 | |
| 1,310,481 | Institution | 0.69% | 30,193,482 | |
| 802,299 | Institution | 0.42% | 18,484,969 | |
| 802,019 | Institution | 0.42% | 18,478,518 | |
| 787,327 | Institution | 0.42% | 18,140,014 | |
| 699,643 | Institution | 0.37% | 16,119,775 | |
| 673,688 | Institution | 0.36% | 15,521,772 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,505,565 | Institution | 2.38% | 105,475,277 | |
| 3,833,510 | Institution | 2.03% | 88,324,070 | |
| 3,535,986 | Institution | 1.87% | 82,777,432 | |
| 2,629,546 | Institution | 1.39% | 59,269,967 | |
| 2,195,265 | Institution | 1.16% | 51,391,154 | |
| 1,943,824 | Institution | 1.03% | 45,504,920 | |
| 983,477 | Institution | 0.52% | 22,659,310 | |
| 789,471 | Institution | 0.42% | 18,189,412 | |
| 708,301 | Institution | 0.37% | 15,965,105 | |
| 640,638 | Institution | 0.34% | 14,997,336 |
FAQ
Who Owns BridgeBio Pharma Inc (BBIO)?
According to the latest TipRanks data, approximately 46.04% of the company's stock is held by institutional investors, 20.66% is held by insiders, and 4.27% is held by retail investors.
What percentage of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 46.04% of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors.
What percentage of BridgeBio Pharma Inc (BBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.27% of BridgeBio Pharma Inc (BBIO) stock is held by retail investors.
Who owns the most shares of BridgeBio Pharma Inc (BBIO)?
KKR Genetic Disorder L.P. owns the most shares of BridgeBio Pharma Inc (BBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.